the cove in 19 vaccine developed by Chinese companies, See Novak Biotech was found to trigger a quick immune response, according to preliminary trial results published on Wednesday, although the level of antibodies produced was lower than in people who had recovered from the disease, The findings were published in a peer reviewed paper and medical journal, The Lancet Infectious Diseases.
灣在 19 疫苗開發的中國公司,見諾瓦克生物技術公司被發現觸發快速的免疫反應,根據初步試驗結果發表在週三,雖然產生的抗體水準低於人已從疾病中恢復,調查結果發表在同行評審論文和醫學雜誌,柳葉刀傳染病。